UK national screening committee

Thousands more black men in the UK will be invited to participate in a prostate cancer screening trial as the health secretary declines to endorse population-wide testing. The decision follows a recommendation from the UK national screening committee, which limits screening to high-risk men with a gene mutation.

Most UK men will not be offered prostate cancer screening if the government adopts expert committee guidance stating mass screening 'likely to cause more harm than good'. The UK National Screening Committee (UKNSC) criticized the use of the prostate-specific antigen (PSA) test for detecting the disease.